Plasma-derived medicinal products: ALT testing - Scientific guideline

HumanScientific guidelines

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

This document aims to assess the vaule of ALT testing with respect to the viral safety of plasma-derived medicinal products.

Keywords: ALT testing, viral safety, plasma-derived medicinal products

Current effective version

Position Paper on Plasma-Derived Medicinal Products: Alt Testing (Corrigendum, Sept. 1999)

Adopted Reference Number: CPMP/BWP/385/99 Legal effective date: 31/07/1999

English (EN) (39.47 KB - PDF)

First published: 29/07/1999 Last updated: 29/07/1999